GlassScriptPhysician profile
Tingting Chen
NPI 1184231797
$2,448.41
in general payments reported to CMS, 2019-2025
18 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $841 · 2022: $450 · 2023: $237 · 2024: $596 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $502.73 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $425.68 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $349.49 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $239.44 | 2021 | |
| Amgen INC. | $220.43 | 2024-2025 | Repatha, Evenity, Repatha |
| Glaxosmithkline, LLC. | $211.01 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $133.99 | 2022-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $59.09 | 2021-2022 | |
| Pfizer INC. | $53.99 | 2022-2023 | |
| Ardelyx, INC. | $42.27 | 2024 | Ibsrela |
| Lilly USA, LLC | $40.31 | 2023 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.08 | 2021-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $29.33 | 2022 | |
| Acella Pharmaceuticals, LLC | $24.24 | 2025 | NP Thyroid 60 |
| Exact Sciences Corporation | $21.56 | 2024 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $20.00 | 2021 | |
| Seqirus USA INC | $17.63 | 2022 | |
| Redhill Biopharma INC. | $17.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tingting Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.